HOWL
Werewolf Therapeutics, Inc.
NASDAQ · Healthcare · Biotechnology · US
$0.97
+2.38%Next report
Analyst consensus
- Next report date
- Nov 3, 2026
- EPS estimate
- -$0.22
- Revenue estimate
- $18.3M
Latest reported
- Last report date
- Jul 31, 2026
- EPS actual
- $0.08
- EPS estimate
- -$0.28
- Revenue actual
- $21.0M
- Revenue estimate
- $21.0M
Track record
Trailing twelve quarters
- EPS beats (12Q)
- 9
- EPS misses (12Q)
- 3
- EPS in line (12Q)
- 0
- Avg surprise (4Q)
- +50.6%
- Revenue beats (12Q)
- 3
Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Nov 3, 2026